Susceptibility of larval zebrafish to the seizurogenic activity of GABA type A receptor antagonists.

Animals Brain / drug effects Bridged-Ring Compounds / toxicity Drug Evaluation, Preclinical / methods GABA-A Receptor Antagonists / toxicity Pentylenetetrazole / toxicity Picrotoxin / toxicity Seizures / chemically induced Zebrafish
Chemical threat agents Picrotoxin Seizures TETS Tetramethylenedisulfotetramine Zebrafish

Journal

Neurotoxicology
ISSN: 1872-9711
Titre abrégé: Neurotoxicology
Pays: Netherlands
ID NLM: 7905589

Informations de publication

Date de publication:
01 2020
Historique:
received: 06 09 2019
revised: 02 12 2019
accepted: 03 12 2019
pubmed: 8 12 2019
medline: 21 1 2021
entrez: 8 12 2019
Statut: ppublish

Résumé

Previous studies demonstrated that pentylenetetrazole (PTZ), a GABA type A receptor (GABA

Identifiants

DOI: 10.1016/j.neuro.2019.12.001 PMID: 31811871 PMC: PMC6957304
pubmed: 31811871
pii: S0161-813X(19)30138-X
doi: 10.1016/j.neuro.2019.12.001
pmc: PMC6957304
mid: NIHMS1546904
pii:
doi:

Substances chimiques

Bridged-Ring Compounds 0
GABA-A Receptor Antagonists 0
Picrotoxin 124-87-8
tetramethylenedisulfotetramine F6TS3WME05
Pentylenetetrazole WM5Z385K7T

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-234

Subventions

Organisme : NINDS NIH HHS
ID : R21 NS110647
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001860
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS079202
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001861
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM099608
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Toxicol Lett. 1988 Aug;42(2):117-22
pubmed: 2457262
Prog Neurobiol. 2003 Sep;71(1):67-80
pubmed: 14611869
Toxicol Sci. 2012 Dec;130(2):362-72
pubmed: 22889812
Dis Model Mech. 2010 Mar-Apr;3(3-4):144-8
pubmed: 20212082
J Pharmacol Exp Ther. 1994 Sep;270(3):1223-9
pubmed: 7932175
J Nat Prod. 2017 May 26;80(5):1548-1557
pubmed: 28485933
Genes Brain Behav. 2015 Jun;14(5):428-38
pubmed: 25906812
Toxicol Appl Pharmacol. 1968 Nov;13(3):307-15
pubmed: 5726659
Forensic Sci Int. 2011 Jan 30;204(1-3):e24-7
pubmed: 20678875
Life Sci. 1984 Oct 1;35(14):1439-44
pubmed: 6090836
Epilepsia. 2018 Oct;59 Suppl 2:92-99
pubmed: 30159887
Dis Model Mech. 2012 Nov;5(6):773-84
pubmed: 22730455
J Pharmacol Toxicol Methods. 2008 May-Jun;57(3):176-87
pubmed: 18337127
Life Sci. 1986 Nov 17;39(20):1855-62
pubmed: 2430161
Proc Am Thorac Soc. 2010 Jul;7(4):254-6
pubmed: 20601628
Indian J Pharm Sci. 2014 Mar;76(2):157-63
pubmed: 24843189
Chemistry. 2017 Jun 22;23(35):8466-8472
pubmed: 28411375
Arch Toxicol. 2004 Jan;78(1):1-6
pubmed: 14551672
J Toxicol Sci. 2014 Aug;39(4):579-600
pubmed: 25056783
Toxicol Appl Pharmacol. 2001 May 1;172(3):233-40
pubmed: 11312652
Exp Neurol. 1988 Aug;101(2):267-75
pubmed: 3396644
Neurosci Lett. 2018 Apr 3;671:33-37
pubmed: 29410359
Epilepsy Res. 1992 Jul;12(2):87-110
pubmed: 1396544
Clin Neuropharmacol. 2008 Jan-Feb;31(1):57-61
pubmed: 18303492
Toxicol Appl Pharmacol. 2014 Dec 1;281(2):185-94
pubmed: 25448683
Physiol Behav. 2012 Dec 5;107(5):773-80
pubmed: 22313674
Toxicol Lett. 2019 Jun 15;308:50-55
pubmed: 30940550
Anal Chem. 2017 May 16;89(10):5612-5619
pubmed: 28398746
Neurotherapeutics. 2007 Jan;4(1):18-61
pubmed: 17199015
Hum Genet. 2012 Jun;131(6):977-1008
pubmed: 22207143
Ann Clin Transl Neurol. 2017 Apr 26;4(6):411-414
pubmed: 28589168
PLoS One. 2016 Jul 14;11(7):e0159472
pubmed: 27416023
eNeuro. 2017 Aug 14;4(4):
pubmed: 28812061
Neuropharmacology. 2000 Apr 27;39(7):1184-96
pubmed: 10760361
Brain Res. 1979 Dec 21;179(1):147-56
pubmed: 41615
Neurotoxicology. 2012 Mar;33(2):207-11
pubmed: 22056734
Sci Rep. 2015 Oct 22;5:15591
pubmed: 26489395
Chem Res Toxicol. 1991 Mar-Apr;4(2):162-7
pubmed: 1664255
Toxicol Appl Pharmacol. 2012 Nov 15;265(1):113-21
pubmed: 23022509
PLoS One. 2013 Nov 14;8(11):e79765
pubmed: 24244558
Brain Res. 2010 Aug 12;1348:209-15
pubmed: 20547142
Ann Emerg Med. 2005 Jun;45(6):609-13
pubmed: 15940093
PLoS One. 2013;8(1):e54166
pubmed: 23342097
Neuroscience. 2005;131(3):759-68
pubmed: 15730879
Mamm Genome. 2018 Feb;29(1-2):90-100
pubmed: 29368091
Genetics. 2014 Sep;198(1):167-70
pubmed: 25009150
Sci Rep. 2016 Jun 16;6:28248
pubmed: 27305978
J Pharmacol Toxicol Methods. 2017 Nov;88(Pt 1):56-63
pubmed: 28712933
Neurobiol Dis. 2020 Jan;133:104491
pubmed: 31176716
Toxicology. 2004 May 20;198(1-3):279-84
pubmed: 15138053
J Pharmacol Exp Ther. 2012 May;341(2):435-46
pubmed: 22328574
PLoS One. 2018 Apr 27;13(4):e0196083
pubmed: 29702678
Toxicol Sci. 2010 Aug;116(2):623-31
pubmed: 20498005
J Pharmacol Exp Ther. 1988 Mar;244(3):802-6
pubmed: 2855243
Drug Chem Toxicol. 1997 Aug;20(3):115-31
pubmed: 9292273
PLoS One. 2017 Apr 18;12(4):e0175420
pubmed: 28419104
Pharmacol Ther. 2007 Oct;116(1):20-34
pubmed: 17531325
Arch Toxicol. 2018 Feb;92(2):833-844
pubmed: 29038840
J Neurophysiol. 1989 Feb;61(2):417-26
pubmed: 2918363
Epilepsy Res. 2000 Jan;38(1):1-14
pubmed: 10604601
Epilepsia. 1996 Mar;37(3):269-74
pubmed: 8598186
Sci Rep. 2017 Jun 8;7(1):3099
pubmed: 28596539
ACS Chem Neurosci. 2018 Jul 18;9(7):1652-1662
pubmed: 29672015
Brain Res. 2019 Jan 15;1703:31-40
pubmed: 29481795
Epilepsy Behav. 2017 May;70(Pt A):224-231
pubmed: 28437751
Dev Neurobiol. 2012 Feb;72(2):186-98
pubmed: 21692188
Neurobiol Dis. 2020 Jan;133:104335
pubmed: 30468862
Neurosci Lett. 2004 Jan 23;355(1-2):77-80
pubmed: 14729239
Epilepsia. 2018 Oct;59 Suppl 2:220-227
pubmed: 29453777

Auteurs

Suren B Bandara (SB)

Department of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: sbandara@ucdavis.edu.

Dennis R Carty (DR)

Department of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: drcarty@ucdavis.edu.

Vikrant Singh (V)

Department of Pharmacology, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: vssingh@ucdavis.edu.

Danielle J Harvey (DJ)

Department of Public Health Sciences, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: djharvey@ucdavis.edu.

Natalia Vasylieva (N)

Department of Entomology, University of California, Davis, College of Agricultural and Environmental Sciences, Davis, CA 95616, United States. Electronic address: nvasylieva@ucdavis.edu.

Brandon Pressly (B)

Department of Pharmacology, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: bpressly@ucdavis.edu.

Heike Wulff (H)

Department of Pharmacology, University of California, Davis, School of Medicine, Davis, CA 95616, United States. Electronic address: hwulff@ucdavis.edu.

Pamela J Lein (PJ)

Department of Molecular Biosciences, University of California, Davis, School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: pjlein@ucdavis.edu.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Composés polycycliques › Composés pontés › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents GABA › Antagonistes GABA › Antagonistes du récepteur GABA-A › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azépines › Pentétrazol › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Préparations pharmaceutiques › Extraits de plantes › Picrotoxine › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Crises épileptiques › Susceptibility of larval zebrafish to the...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Poissons › Cypriniformes › Cyprinidae › Danio zébré › Susceptibility of larval zebrafish to the...